Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor - ScienceDirect
Rimonabant - Wikipedia
Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates
Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects | Molecular Pharmacology
Structure Activity of CB1 Cannabinoid Receptor Antagonists
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor - ScienceDirect
Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related Risks | Circulation
Structure Activity of CB1 Cannabinoid Receptor Antagonists
Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators | SpringerLink
Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors - ScienceDirect
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice | Arteriosclerosis, Thrombosis, and Vascular Biology
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice | Arteriosclerosis, Thrombosis, and Vascular Biology
Blockade by the Cannabinoid CB1 Receptor Antagonist, Rimonabant (SR141716), of the Potentiation by Quinelorane of Food-Primed Reinstatement of Food-Seeking Behavior | Neuropsychopharmacology
CB1 antagonists for obesity—what lessons have we learned from rimonabant? | Nature Reviews Endocrinology
Rimonabant - Wikipedia
Docking of rimonabant and THC to the CB1 receptor (a) Overlay of the... | Download Scientific Diagram
PDF) The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Cell Proliferation and Increases Markers of Adipocyte Maturation in Cultured Mouse 3T3 F442A Preadipocytes
Structure Activity of CB1 Cannabinoid Receptor Antagonists
Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators | SpringerLink
Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity - Clinical Trials Arena
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice | Arteriosclerosis, Thrombosis, and Vascular Biology
Rimonabant - Wikipedia
